Hosted on MSN37m
Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...
Ascendis Pharma A/S (NASDAQ:ASND) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 12, 2025 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699, expectations were $-1.32. Operator: Good day and thank you for standing ...